Urothelial carcinoma involving the prostate: The association of revised tumour stage and coexistent bladder cancer with survival after radical cystectomy

BJU International

Volumn 114, Issue 6, 2014, Pages 832-836

  Knoedler, John J ^a   Boorjian, Stephen A ^a   Tollefson, Matthew K ^a   Cheville, John C ^a   Thapa, Prabin ^a   Tarrell, Robert F ^a   Frank, Igor ^a  

^a MAYO CLINIC   (United States)

Author keywords

bladder cancer; cystectomy; invasion; prostate; urethra; urothelial carcinoma

Indexed keywords

ARTICLE; BLADDER CANCER; CANCER CLASSIFICATION; CANCER MORTALITY; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CYSTECTOMY; DISEASE ASSOCIATION; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; RISK FACTOR; SURVIVAL TIME; TRANSITIONAL CELL CARCINOMA; TUMOR INVASION; AGED; CARCINOMA, TRANSITIONAL CELL; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOLOGY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDY; SECONDARY; URINARY BLADDER NEOPLASMS;

AGED; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS;

EID: 84902542349     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12486     Document Type: Article

References (20)

1. Siegel R, Naishadham D, Jemal A,. Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10-29
2. Donat SM, Wei DC, McGuire MS, Herr HW,. The efficacy of transurethral biopsy for predicting the long-term clinical impact of prostatic invasive bladder cancer. J Urol 2001; 165: 1580-1584
3. Nixon RG, Chang SS, Lafleur BJ, Smith JA Jr, Cookson MS,. Carcinoma in situ and tumor multifocatlity predict the risk of prostatic urethral involvement at radical cystectomy in men with transitional cell carcinoma of the bladder. J Urol 2002; 167: 502-505
4. Esrig D, Freeman JA, Elmajian DA, et al. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion. J Urol 1996; 156: 1071-1076
5. Revelo MP, Cookson MS, Chang SS, Shook MF, Smith JA Jr, Shappell SB,. Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery. J Urol 2004; 171: 646-651
6. Wood DP Jr, Montie JE, Pontes JE, VanderBrug Medendorp S, Levin HS,. Transitional cell carcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer. J Urol 1989; 141: 346-349
7. Herr HW, Donat SM,. Prostatic tumor relapse in patients with superficial bladder tumors: 15-year outcome. J Urol 1999; 161: 1854-1857
8. Lerner SP, Shen S,. Pathologic assessment and clinical significance of prostatic involvement by transitional cell carcinoma and prostate cancer. Urol Oncol 2008; 26: 481-485
9. Donat SM, Genega EM, Herr HW, Reuter VE,. Mechanisms of prostatic stromal invasion in patients with bladder cancer: clinical significance. J Urol 2001; 165: 1117-1120
10. Hardeman SW, Perry A, Soloway MS,. Transitional cell carcinoma of the prostate following intravesical therapy for transitional cell carcinoma of the bladder. J Urol 1988; 140: 289-292
11. Pettus JA, Al-Ahmadie H, Barocas DA, et al. Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy. Eur Urol 2008; 53: 370-375
12. Ayyathurai R, Gomez P, Luongo T, Soloway MS, Manoharan M,. Prostatic involvement by urothelial carcinoma of the bladder: clinicopathological features and outcome after radical cystectomy. BJU Int 2007 100: 1021-1025
13. Barocas DA, Patel SG, Chang SS, Clark PE, Smith JA Jr, Cookson MS,. Outcomes of patients undergoing radical cystoprostatectomy for bladder cancer with prostatic involvement on final pathology. BJU Int 2009; 104: 1091-1097
14. Tilki D, Svatek RS, Karakiewicz PI, et al. Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patients. J Urol 2010 183: 87-93
15. Shen SS, Lerner SP, Muezzinoglu B, Truong LD, Amiel G, Wheeler TM,. Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance. Hum Pathol 2006; 37: 726-734
16. Oliva IV, Smith SL, Chen Z, Osunkoya AO,. Urothelial carcinoma of the bladder with transmural and direct prostatic stromal invasion: does extent of stromal invasion significantly impact patient outcome? Hum Pathol 2011; 42: 51-56
17. Njinou Ngninkeu B, Lorge F, Moulin P, Jamart J, Van Cangh PJ,. Transitional cell carcinoma involving the prostate: a clinicopathological retrospective study of 76 cases. J Urol 2003; 169: 149-152
18. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. AJCC Cancer Staging Manual, 7th edn. New York: Springer, 2010
19. Patel AR, Cohn JA, Abd El Latif A, et al. Validation of new AJCC exclusion criteria for subepithelial prostatic stromal invasion from pT4a bladder urothelial carcinoma. J Urol 2013; 189: 53-58
20. Pagano F, Bassi P, Ferrante GL, et al. Is stage pT4a (D1) reliable in assessing transitional cell carcinoma involvement of the prostate in patients with a concurrent bladder cancer? A necessary distinction for contiguous or noncontiguous involvement. J Urol 1996; 155: 244-247